Ameriprise’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.9M Sell
624,260
-37,981
-6% -$908K ﹤0.01% 1672
2025
Q4
$17.7M Sell
662,241
-22,641
-3% -$541K ﹤0.01% 1504
2025
Q3
$14.6M Buy
684,882
+48,429
+8% +$1.15M ﹤0.01% 1622
2025
Q2
$13.7M Sell
636,453
-60,372
-9% -$1.12M ﹤0.01% 1592
2025
Q1
$11.6M Sell
696,825
-188,045
-21% -$3.42M ﹤0.01% 1662
2024
Q4
$16.2M Buy
884,870
+120,996
+16% +$1.95M ﹤0.01% 1475
2024
Q3
$11.7M Buy
763,874
+21,228
+3% +$354K ﹤0.01% 1655
2024
Q2
$12.1M Buy
742,646
+463
+0.1% +$7.47K ﹤0.01% 1593
2024
Q1
$13.7M Buy
742,183
+95,071
+15% +$2.36M ﹤0.01% 1532
2023
Q4
$20.3M Buy
647,112
+67,605
+12% +$1.61M 0.01% 1270
2023
Q3
$12.1M Buy
579,507
+11,461
+2% +$311K ﹤0.01% 1548
2023
Q2
$13.6M Sell
568,046
-12,429
-2% -$276K ﹤0.01% 1527
2023
Q1
$10.9M Buy
580,475
+57,179
+11% +$1.09M ﹤0.01% 1706
2022
Q4
$8.33M Sell
523,296
-406,511
-44% -$6.35M ﹤0.01% 1897
2022
Q3
$15.2M Sell
929,807
-15,253
-2% -$247K 0.01% 1367
2022
Q2
$13.3M Sell
945,060
-134,481
-12% -$2.51M ﹤0.01% 1505
2022
Q1
$26.1M Sell
1,079,541
-78,757
-7% -$1.91M 0.01% 1157
2021
Q4
$27M Buy
1,158,298
+29,518
+3% +$594K 0.01% 1192
2021
Q3
$18.8M Sell
1,128,780
-169,958
-13% -$3.28M 0.01% 1316
2021
Q2
$31.7M Sell
1,298,738
-1,135,313
-47% -$25.6M 0.01% 1034
2021
Q1
$62.8M Buy
2,434,051
+1,168,541
+92% +$51.4M 0.02% 680
2020
Q4
$67.7M Buy
1,265,510
+49,503
+4% +$2.46M 0.02% 606
2020
Q3
$50.2M Sell
1,216,007
-950,967
-44% -$41.1M 0.02% 640
2020
Q2
$105M Buy
2,166,974
+574,958
+36% +$27.6M 0.05% 379
2020
Q1
$67.3M Buy
1,592,016
+713,916
+81% +$29.4M 0.04% 452
2019
Q4
$37.6M Sell
878,100
-122,394
-12% -$5.32M 0.02% 830
2019
Q3
$36M Buy
1,000,494
+530,622
+113% +$16.1M 0.02% 810
2019
Q2
$12.6M Sell
469,872
-62,797
-12% -$1.6M 0.01% 1551
2019
Q1
$14.3M Buy
532,669
+168,178
+46% +$3.93M 0.01% 1391
2018
Q4
$5.89M Sell
364,491
-469
-0.1% -$9.11K ﹤0.01% 2016
2018
Q3
$7.56M Sell
364,960
-577,268
-61% -$9.08M ﹤0.01% 2077
2018
Q2
$14.4M Buy
942,228
+70,908
+8% +$1.26M 0.01% 1434
2018
Q1
$19.6M Buy
871,320
+25,380
+3% +$703K 0.01% 1132
2017
Q4
$25.5M Sell
845,940
-46,066
-5% -$1.47M 0.01% 928
2017
Q3
$33.6M Sell
892,006
-125,546
-12% -$4.08M 0.02% 722
2017
Q2
$28.4M Buy
1,017,552
+134,830
+15% +$4.02M 0.01% 798
2017
Q1
$30.3M Buy
882,722
+506,605
+135% +$17.9M 0.02% 754
2016
Q4
$10.8M Buy
376,117
+66,536
+21% +$1.76M 0.01% 1463
2016
Q3
$9.85M Sell
309,581
-120,384
-28% -$4.08M 0.01% 1469
2016
Q2
$14M Sell
429,965
-12,353
-3% -$413K 0.01% 1146
2016
Q1
$12.4M Buy
442,318
+204,148
+86% +$4.45M 0.01% 1259
2015
Q4
$8.49M Buy
238,170
+129,075
+118% +$4.55M 0.01% 1573
2015
Q3
$3.61M Buy
109,095
+22,315
+26% +$928K ﹤0.01% 2237
2015
Q2
$3.63M Sell
86,780
-3,727
-4% -$144K ﹤0.01% 2355
2015
Q1
$2.95M Sell
90,507
-229,014
-72% -$7.87M ﹤0.01% 2390
2014
Q4
$10.1M Sell
319,521
-61,260
-16% -$1.74M 0.01% 1488
2014
Q3
$9.43M Sell
380,781
-17,663
-4% -$413K 0.01% 1520
2014
Q2
$9M Sell
398,444
-154,886
-28% -$3.23M 0.01% 1634
2014
Q1
$13.5M Buy
553,330
+301,548
+120% +$7.63M 0.01% 1283
2013
Q4
$6.29M Sell
251,782
-15,266
-6% -$360K ﹤0.01% 1847
2013
Q3
$7.34M Sell
267,048
-23,737
-8% -$496K ﹤0.01% 1679
2013
Q2
$5.28M Buy
+290,785
New +$4.01M ﹤0.01% 1858

Other funds holding ACAD